| Literature DB >> 34208927 |
Anastasija Panevska1, Gordana Glavan1, Anita Jemec Kokalj1, Veronika Kukuljan2, Tomaž Trobec3, Monika Cecilija Žužek3, Milka Vrecl3, Damjana Drobne1, Robert Frangež3, Kristina Sepčić1.
Abstract
Aegerolysin proteins ostreolysin A6 (OlyA6), pleurotolysin A2 (PlyA2) and erylysin A (EryA) produced by the mushroom genus Pleurotus bind strongly to an invertebrate-specific membrane sphingolipid, and together with a protein partner pleurotolysin B (PlyB), form transmembrane pore complexes. This pore formation is the basis for the selective insecticidal activity of aegerolysin/PlyB complexes against two economically important coleopteran pests: the Colorado potato beetle and the western corn rootworm. In this study, we evaluated the toxicities of these aegerolysin/PlyB complexes using feeding tests with two ecologically important non-target arthropod species: the woodlouse and the honey bee. The mammalian toxicity of the EryA/PlyB complex was also evaluated after intravenous administration to mice. None of the aegerolysin/PlyB complexes were toxic against woodlice, but OlyA6/PlyB and PlyA2/PlyB were toxic to honeybees, with 48 h mean lethal concentrations (LC50) of 0.22 and 0.39 mg/mL, respectively, in their food. EryA/PlyB was also tested intravenously in mice up to 3 mg/kg body mass, without showing toxicity. With no toxicity seen for EryA/PlyB for environmentally beneficial arthropods and mammals at the tested concentrations, these EryA/PlyB complexes are of particular interest for development of new bioinsecticides for control of selected coleopteran pests.Entities:
Keywords: Apis mellifera; MACPF protein; Porcellio scaber; adverse effects; aegerolysins; bioinsecticides; erylysin A; non-target organisms; oyster mushroom; toxicity
Mesh:
Substances:
Year: 2021 PMID: 34208927 PMCID: PMC8310125 DOI: 10.3390/toxins13070457
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Feeding (A) and defecation (B) rates of the woodlice exposed to 9.0 µg/cm2 aegerolysin/pleurotolysin B (PlyB) complex (0.5 mg ostreolysin A6 (OlyA6), pleurotolysin A2 (PlyA2) or erylysin A (EryA) supplemented with 0.04 mg/mL PlyB) for 7 days. Data are means ± standard error (n = 10 woodlice exposed per treatment).
Figure 2Feeding (A) and survival (B) rates of honeybees feeding on 0.5 mg/mL OlyA6, PlyA2 or EryA without (grey bars) and with (white bars) 0.04 mg/mL PlyB over 48 h. Data are means ± standard error (n = 3 groups of bees per treatment).
Figure 3Feeding (A) and survival (B) rates of honeybees feeding on increasing concentrations of OlyA6/PlyB and PlyA2/PlyB for 48 h. The sigmoid curves for the data fitting for the LC50 values are shown in Figure S1. Data are means ± standard error (n = 3 groups of bees exposed per treatment).
Body and organ mass of mice after 24 h exposure to increasing doses of intravenous EryA/PlyB (40:1 molar ratio).
| EryA/PlyB | Body Mass | Relative Organ Mass (% Body Mass) | |||
|---|---|---|---|---|---|
| (mg/kg) | (g) | Liver | Lung | Kidney | Heart |
| 0 | 23.56 ± 0.41 | 4.33 ± 0.16 | 0.82 ± 0.25 | 0.67 ± 0.06 | 0.58 ± 0.05 |
| 0.5 | 24.40 ± 0.52 | 4.07 ± 0.05 | 0.83 ± 0.24 | 0.71 ± 0.02 | 0.57 ± 0.07 |
| 1.0 | 24.46 ± 1.53 | 4.25 ± 0.23 | 0.87 ± 0.14 | 0.67 ± 0.03 | 0.63 ± 0.13 |
| 3.0 | 24.50 ± 0.54 | 4.15 ± 0.15 | 0.83 ± 0.17 | 0.69 ± 0.02 | 0.58 ± 0.05 |
| 0.304 | 0.097 | 0.977 | 0.245 | 0.720 | |
Data are means ± standard deviation (n = 5 mice per group).
Figure 4Representative photomicrographs of hematoxylin/eosin-stained liver, kidney, lung and heart sections 24 h after control and 3 mg/kg EryA/PlyB intravenous injection of the mice. Liver: arrowheads, karyomegaly (polyploidization); arrow, inflammatory cell infiltration; cv, central vein. Kidney: g, glomerulus. Lungs: a, alveoli; ad, alveolar duct; ac, alveolar sac; b, bronchiole; tb, terminal bronchiole. Heart: m, myocardium; v, coronary vessel. Scale bars, 50 µm (liver, kidney, heart); 250 µm (lung).